Bitter pill
Bayer AG has agreed to pay the US government US $257 million after it was found guilty of overcharging for its antibiotic drug Cipro. The company admitted to selling Cipro to healthcare provider Kaiser Permanente at a price lower than what it was billing the government-aided Medicaid programme. This action violates a US law that requires drug companies to supply their medicines to Medicaid at the lowest cost to any purchaser.
Related Content
- Centre tries flavoured pills to help kids finish TB treatment
- Discarded medicines are bitter pills for environment
- NGT directive a bitter pill for sugar mills discharging effluents into Ganga
- In new pharma pricing policy, hope beyond bitter pill
- A bitter pill
- Disadvantage Assam, dam tug of war adds to confusion